Adverse events are frequent in NTM pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus and GI upset. These opinions can provide assistance in individual patient management decisions.
Management of drug toxicity in M. avium complex pulmonary disease - an expert panel survey / J. van Ingen, S. Aliberti, C. Andrejak, J.D. Chalmers, L.R. Codecasa, C.L. Daley, N. Hasegawa, D.E. Griffith, W. Hoefsloot, G. Huitt, J. Jarand, B.W. Jhun, M.R. Loebinger, T.K. Marras, K. Morimoto, E. Polverino, F.C. Ringshausen, M. Santin, R. Thomson, D. Wagner, R.J. Wallace, K.L. Winthrop, J. Yim. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 73:1(2021 Jul 01), pp. e256-e259. [10.1093/cid/ciaa1361]
Management of drug toxicity in M. avium complex pulmonary disease - an expert panel survey
S. AlibertiSecondo
Conceptualization
;
2021
Abstract
Adverse events are frequent in NTM pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus and GI upset. These opinions can provide assistance in individual patient management decisions.
| File | Dimensione | Formato | |
|---|---|---|---|
|
ciaa1361.pdf
accesso aperto
Tipologia:
Pre-print (manoscritto inviato all'editore)
Dimensione
550.08 kB
Formato
Adobe PDF
|
550.08 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
